Marriage Counselors in Duvall, WA Accepting Medicare

6 Marriage Counselors found. Showing 1 - 6

Mrs. Lynn Christine Smythe, M.S, LMFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 15315 1st Ave Ne, Suite #212, Duvall, WA 98019 Phone: 425-736-8862    Fax: 360-794-7252

Mrs. Aubrey Christine Lane, LMFTA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: Larch Counseling 15315 1st Avenue Northeast, #205-a, Duvall, WA 98019 Phone: 425-200-0130

Christina Campos, MA, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 26420 Ne Virginia St Ste 1, Duvall, WA 98019 Phone: 425-628-5888

Mrs. Karin E Linderoth Reep, M.A., L.M.F.T. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 15321 Main St.ne, Suite 316, Duvall, WA 98019 Phone: 425-788-9921    Fax: 425-788-9921

Ms. Cora Bond Lombardi, MA LMFTA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 15315 1st Ave Ne, Suite 206, Duvall, WA 98019 Phone: 425-681-2036

Dan Claussen Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 15315 Ne 1st Ave Ne, Suite 205-a, Duvall, WA 98019 Phone: 425-200-0130

News Archive

New research initiative to investigate multi-species response to novel coronavirus

Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).

Bacterium that causes Q fever associated with increased risk of lymphoma

The bacterium that causes Q fever, an infectious disease that humans contract from animals, is associated with an increased risk of lymphoma, according to a study published online today in Blood, the Journal of the American Society of Hematology.

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, announced today it has entered into a research collaboration agreement with the PATH Malaria Vaccine Initiative (MVI) to conduct proof-of-concept studies with its proprietary, recombinant vesicular stomatitis virus (rVSV) vector technology as a preventative malaria vaccine.

Abiomed's Impella cVAD device awarded CE Mark

Abiomed, Inc., a leading provider of break-through heart support technologies, today announced it has received CE Marking approval in the European Union to market the Impella cVAD device, a new percutaneous Impella® heart pump that provides peak flow of approximately 4 liters of blood per minute.

MicroStockProfit.com releases investment report on AEterna Zentaris

MicroStockProfit.com announces an investment report featuring AEterna Zentaris Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

Read more Medical News

› Verified 2 days ago